Colorectal Carcinoma
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Leukemia, T-Cell
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, these results suggest that the cytoplasmic interplay of Tax and p100 may play an important role in the initiation and maintenance of HTLV-1 latency observed in adult T-cell leukemia.
|
8289813 |
1994 |
Adult T-Cell Lymphoma/Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, these results suggest that the cytoplasmic interplay of Tax and p100 may play an important role in the initiation and maintenance of HTLV-1 latency observed in adult T-cell leukemia.
|
8289813 |
1994 |
Human immunodeficiency virus (HIV) II infection category B1
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the physical interaction of Tax with p100 leads to the inhibition of Tax-induced activation of the HTLV-I and human immunodeficiency virus type 1 long terminal repeats, reflecting p100-mediated cytoplasmic sequestration of the normally nuclearly expressed Tax protein.
|
8289813 |
1994 |
Malignant neoplasm of breast
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
However, although p100 is highly expressed in a number of breast cancer cell lines, MHC Class I antigen expression was observed on all the cell lines we analysed and could be further induced by stimulation with the cytokines IFN-gamma or TNF-alpha.
|
9681829 |
1998 |
Breast Carcinoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
However, although p100 is highly expressed in a number of breast cancer cell lines, MHC Class I antigen expression was observed on all the cell lines we analysed and could be further induced by stimulation with the cytokines IFN-gamma or TNF-alpha.
|
9681829 |
1998 |
Color vision defect
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Central or paracentral scotomata, color vision defects and delayed P100 latencies in the VEP were seen.
|
10447644 |
1999 |
Color blindness
|
0.010 |
Biomarker
|
disease |
BEFREE |
Central or paracentral scotomata, color vision defects and delayed P100 latencies in the VEP were seen.
|
10447644 |
1999 |
Carcinoma of lung
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
DIL-1 (differentially expressed in cancerous and noncancerous lung cells; HGMW-approved symbol SPON2) and pulmonary surfactant apoprotein A were expressed in normal lung tissues but not in lung carcinoma cell lines, whereas DIL-2 (HGMW-approved symbol C20orf2) and nm23-H1 were expressed in lung carcinoma cell lines but not in normal lung tissues.
|
10512675 |
1999 |
Colorectal Carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Twelve genes, including Smad5 and Fls353, have previously been shown to be overexpressed in CRC.
|
10601642 |
1999 |
Multiple Myeloma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
C-terminal truncations of the NFKB2 p100 gene product have been observed in a number of cases of human cutaneous T cell lymphomas, as well as human B-cell lymphomas and myelomas.
|
10713675 |
2000 |
Lymphoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Assays of a series of additional lymphoma-associated NF-kappaB-2 truncation suggested that the C-terminal truncation associated with these proteins was also associated with a loss of the IkappaB-like activities of p100 NF-kappaB-2, for at least some NF-kappaB target promoters.
|
10713675 |
2000 |
Lymphoma, T-Cell, Cutaneous
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
C-terminal truncations of the NFKB2 p100 gene product have been observed in a number of cases of human cutaneous T cell lymphomas, as well as human B-cell lymphomas and myelomas.
|
10713675 |
2000 |
Adult Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Assays of a series of additional lymphoma-associated NF-kappaB-2 truncation suggested that the C-terminal truncation associated with these proteins was also associated with a loss of the IkappaB-like activities of p100 NF-kappaB-2, for at least some NF-kappaB target promoters.
|
10713675 |
2000 |
Childhood Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Assays of a series of additional lymphoma-associated NF-kappaB-2 truncation suggested that the C-terminal truncation associated with these proteins was also associated with a loss of the IkappaB-like activities of p100 NF-kappaB-2, for at least some NF-kappaB target promoters.
|
10713675 |
2000 |
Liver carcinoma
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
Two other Ags (HCA519 and HCA90) were highly overexpressed in HCC and also expressed in cancer cell lines of lung, prostate, and pancreas, but not in the respective normal tissues.
|
12097419 |
2002 |
Colorectal Carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
After the generation of a profile of genes overexpressed in primary colorectal cancer (CRC) we selected 5 genes, Ese-3b, Fls353, PBEF, SPARC and Smad5 for a more detailed analysis using phage display-derived antibodies.
|
12209988 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
A repp86 labeling index (RI) of more than 10% positive tumor cells significantly predicted a shortened disease-free interval and an increased tumor mortality (both P <.0001).
|
12721258 |
2003 |
Neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
It seems that repp86 expression is closely associated with the biologic behavior of neuroblastoma.
|
12721258 |
2003 |
Central neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
It seems that repp86 expression is closely associated with the biologic behavior of neuroblastoma.
|
12721258 |
2003 |
Childhood Neuroblastoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
It seems that repp86 expression is closely associated with the biologic behavior of neuroblastoma.
|
12721258 |
2003 |
Non-Small Cell Lung Carcinoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
Integrated DNA-RNA analyses identified WHSC1L1 and TPX2 as two candidates likely targeted for amplification in both pancreatic ductal adenocarcinoma and non-small-cell lung cancer.
|
15983384 |
2005 |
Pancreatic Ductal Adenocarcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Integrated DNA-RNA analyses identified WHSC1L1 and TPX2 as two candidates likely targeted for amplification in both pancreatic ductal adenocarcinoma and non-small-cell lung cancer.
|
15983384 |
2005 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Abnormally expressed TPX2 has been reported in various malignancies, but less is known in lung cancer.
|
16489064 |
2006 |
Carcinogenesis
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
The present study appraised the significance of TPX2 aberrant expression for tumorigenesis and progression of human squamous cell carcinoma (SCC) in lung.
|
16489064 |
2006 |